CLASS II Device recall · Reported 29 Sep 2021 · FDA Enforcement Report

Greiner Bio-One Vacuette¿ Tube 9NC Coagulation sodium recalled

Greiner Bio-One North America is recalling Greiner Bio-One Vacuette¿ Tube 9NC Coagulation sodium citrate 3.2% blue cap-white ring, distributed nationwide in the US. The recall was initiated on 20 Aug 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # B210533B Expiration 05/10/22 and B210439J Expiration 04/13/2022.
Quantity recalled956,400

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2507-2021
FDA event ID
88563
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Terminated
Recall initiated
20 Aug 2021
FDA classified
22 Sep 2021
Reported
29 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Aug 2021Recall initiated by company
22 Sep 2021Classified by FDA+33 days
29 Sep 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaint of tubes clotting due to variation of anticoagulant and/or tubes have low vacuum.

Product as listed by the FDA

Greiner Bio-One VACUETTE¿ TUBE 2 ml 9NC Coagulation sodium citrate 3.2% 13x75 blue cap-white ring, sandwich tube, non-ridged

Where it was distributed

US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MD, ME, MO, MT, NC, NE, NM, NV, NY, OH, OR, PA, TX, VA, WA and Puerto Rico.

Nationwide AlabamaArizonaCaliforniaConnecticutFloridaGeorgiaIllinoisIndianaKentuckyLouisianaMarylandMaineMissouriMontanaNorth CarolinaNebraskaNew MexicoNevadaNew YorkOhio

Questions about this recall

Why was it recalled?

Complaint of tubes clotting due to variation of anticoagulant and/or tubes have low vacuum.

Which lots are affected?

Lot # B210533B Expiration 05/10/22 and B210439J Expiration 04/13/2022.

Where was it sold?

US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MD, ME, MO, MT, NC, NE, NM, NV, NY, OH, OR, PA, TX, VA, WA and Puerto Rico.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 17

Other Other Medical Devices recalls

All 13,968